Compound ID | 1862
Synonym(s): ICI 194,660 | SM-7338 | SM7338 | SM 7338
Class: Beta-lactam (carbapenem)
| Spectrum of activity: | Gram-positive & Gram-negative | 
| Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets.Carbapenems have a very broad spectrum incl. non-fermenters and are not hydrolysed by most beta-lactamases with exception of carbapenemases | 
| Description: | Semisynthetic, derived from thienamycin. Fixed combinations with various beta-lactamase inhibitors | 
| Institute where first reported: | Pfizer | 
| Year first mentioned: | 1983 | 
| Highest developmental phase: | Approved by FDA in 1996 | 
| Development status: | Approved, off-patent | 
| Chemical structure(s): | |||||||||||
                               
  | 
                                               
                                               
                                               
                                               
                           
                           
                               
  | 
                                       
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/441130 | 
| Guide to Pharmacology: | meropenem | 
| Citations: | 
                                        
                                            
                                                
                                                
                                                     |